Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)
Clinical trial NCT02179528 · UNKNOWN
Trial details
- NCT number
- NCT02179528
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.